Last reviewed · How we verify
NCT07292064
Type D Personality, Somatization and Perceived Social Support in Temporomandibular Joint Disorders
trial in Temporomandibular Joint Disorders in 90 participants. Completed in 30 June 2025.
30 June 2025
Quick facts
| Lead sponsor | Gulseren Demir Karakilic |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 90 |
| Start date | 20 February 2025 |
| Primary completion | 30 June 2025 |
| Estimated completion | 30 June 2025 |
| Sites | 1 location across Turkey (Türkiye) |
Conditions studied
- Temporomandibular Joint Disorders — all drugs for Temporomandibular Joint Disorders →
- Somatization Disorder — all drugs for Somatization Disorder →
- Type D Personality — all drugs for Type D Personality →
- Perceived Social Support — all drugs for Perceived Social Support →
Sponsor
Gulseren Demir Karakilic
Who can join
Adults 18 to 65, any sex, with Temporomandibular Joint Disorders or Somatization Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aimed to investigate the relationship between Type D personality traits, somatization disorder, and perceived social support in individuals diagnosed with temporomandibular joint disorders. Temporomandibular joint disorders are musculoskeletal and neuromuscular conditions that affect the jaw joint, chewing muscles, and related structures, leading to pain and functional difficulties. Psychological and social factors, such as personality traits and emotional distress, have been shown to influence the development and persistence of these disorders. The research was conducted as a prospective cross-sectional study between February and June 2025 in Gaziantep City Hospital. Adult participants between 18 and 65 years of age who were diagnosed with temporomandibular joint disorders were compared with healthy individuals of similar age and gender. Participants completed validated questionnaires that assessed mandibular function, anxiety and depression symptoms, Type D personality traits, somatization tendencies, and levels of perceived social support. The purpose of this study was to provide a more comprehensive understanding of the psychological and social dimensions that may contribute to the onset and course of temporomandibular joint disorders.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07292064
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Temporomandibular Joint Disorders
Currently open trials in the same condition.
- NCT07317570 — The Effect of Body Awareness Therapy on Pain, Function and Psychosocial Parameters in Temporomandibular Joint Disorders · NA · recruiting
- NCT06763419 — Internal Photobiomodulation For Management Of Temporomandibular Joint Internal Derangement · NA · recruiting
- NCT06721104 — Balance, TMJ, Social Adaptive Assessment in Individuals With Autism Spectrum Disorder · recruiting
- NCT06500390 — Temporomandibular Disorder in Use of Levonorgestrel Intrauterine System · NA · recruiting
- NCT06813040 — Efficacy of Repetitive Transcranial Magnetic Stimulation in Temporomandibular Disorders. · NA · recruiting
Other Gulseren Demir Karakilic trials
Trials by the same sponsor.
- NCT07292181 — Central Sensitization and Neuropathic Pain in Cervicogenic Headache · completed
- NCT07292155 — Type D Personality, and Stigma in Myofascial Pain Syndrome · completed
- NCT07292129 — Smartphone Addiction in Cervicogenic Headache · completed
- NCT07292103 — Trauma Exposure and Childhood Trauma in Temporomandibular Joint Disorders · completed
- NCT07292077 — Restless Legs Syndrome in Temporomandibular Joint Disorders · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07292064 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Gulseren Demir Karakilic
- Last refreshed: 29 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07292064.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing